Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 22, 20 December 2023
Open
Access | Article
Unraveling the Complexity of triple-negative breast cancer: A comprehensive research analysis
* Author to whom correspondence should be addressed.
Abstract
TNBC, also known as triple-negative breast cancer, is a predominantly female-targeting and stands out due to its defining attribute. TNBC accounts for a considerable percentage of BC cases, and unfortunately, it is associated with poor prognoses and limited treatment options. In-depth information about TNBC, including its epidemiology, clinical expression, molecular features, and current diagnostic and treatment options, is provided in this research paper. In addition to examining ongoing research projects to better TNBC patient outcomes and treatment options, the report also suggests potential future routes for improved management tactics. The development of effective targeted treatments and individualized treatment plans for such a challenging disease necessitates an understanding of the distinctive characteristics of TNBC. This article contributes to continuing efforts to meet the unmet clinical requirements of patients affected by this aggressive BC subtype by offering insight into the complexity of TNBC.
Keywords
diagnosis, TNBC, treatment, subtype, risk factors, therapy
References
1. Almansour, Nahlah Makki. “Triple-Negative Breast Cancer: A Brief Review about Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence.” Frontiers in Molecular Biosciences, vol. 9, 25 Jan. 2022.
2. Izci, Filiz, et al. “Psychiatric Symptoms and Psychosocial Problems in Patients with Breast Cancer.” Journal of Breast Health, vol. 12, no. 3, 13 July 2016, pp. 94–101.
3. Saraiva, DianaP, et al. “How Many Diseases Is Triple Negative Breast Cancer: The Protagonism of the Immune Microenvironment.” ESMO Open, vol. 2, no. 4, 2017, p. e000208.
4. CDCBreastCancer. “Triple-Negative Breast Cancer.” Centers for Disease Control and Prevention, 9 Mar. 2022,
5. Ahn, Sung Gwe, et al. “Molecular Classification of Triple-Negative Breast Cancer.” Journal of Breast Cancer, vol. 19, no. 3, 2016, p. 223.
6. Wang, Dong-Yu, et al. “Molecular Stratification within Triple-Negative Breast Cancer Subtypes.” Scientific Reports, vol. 9, no. 1, 13 Dec. 2019, p. 19107, www.nature.com/articles/s41598-019-55710-w#citeas. Accessed 26 Nov. 2020.
7. Alluri, Prasanna, and Lisa A. Newman. “Basal-like and Triple-Negative Breast Cancers.” Surgical Oncology Clinics of North America, vol. 23, no. 3, July 2014, pp. 567–577.
8. Yin, Li, et al. “Triple-Negative Breast Cancer Molecular Subtyping and Treatment Progress.” Breast Cancer Research, vol. 22, no. 1, 9 June 2020.
9. “Breast Cancer Risk: Race and Ethnicity.” Susan G. Komen®, www.komen.org/breast-cancer/risk-factor/race-ethnicity/#:~:text=TNBC%20is%20more%20common%20among.
10. Sun, Heng, et al. “Triple-Negative Breast Cancer and Its Association with Obesity.” Molecular and Clinical Oncology, vol. 7, no. 6, 1 Dec. 2017, pp. 935–942.
11. Dandamudi, Akhila, et al. “Dietary Patterns and Breast Cancer Risk: A Systematic Review.” Anticancer Research, vol. 38, no. 6, 1 June 2018, pp. 3209–3222.
12. “Triple Negative Breast Cancer.” Www.cancerresearchuk.org, www.cancerresearchuk.org/ about-cancer/breast-cancer/types/triple-negative-breast-cancer#:~:text=a%20new%20lump% 20or%20thickening.
13. “Breast Cancer.” MD Anderson Cancer Center, 2020..
14. Dass, Sylvia Annabel, et al. “Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities.” Medicina, vol. 57, no. 1, 12 Jan. 2021, p. 62. Accessed 8 Jan. 2022.
15. Wu, Hsing-Ju, and Pei-Yi Chu. “Current and Developing Liquid Biopsy Techniques for Breast Cancer.” Cancers, vol. 14, no. 9, 19 Apr. 2022, p. 2052.
16. “PET, CT Scans, and Thermagraphy for Breast Cancer Imaging | Saint John’s Cancer Institute.” Breast, www.saintjohnscancer.org/breast/breast-health/breast-evaluation/other-tests/#:~:text= PET%20scans%20are%20not%20used.
17. “Lumpectomy - Mayo Clinic.” Www.mayoclinic.org, www.mayoclinic.org/tests-procedures/ lumpectomy/about/pac-20394650#:~:text=Your%20doctor%20may%20recommend%20lum pectomy.
18. “Breast-Conserving Surgery (Lumpectomy).” Www.hopkinsmedicine.org, www.hopkinsmed icine.org/health/treatment-tests-and-therapies/breast-conserving-surgery.
19. “Mastectomy - Mayo Clinic.” Www.mayoclinic.org, www.mayoclinic.org/tests-procedures/m astectomy/about/pac20394670#:~:text=Mastectomy%20for%20breast%20cancer%20treatment.
20. “Triple-Negative Breast Cancer Treatment: What to Expect.” Healthline, 14 June 2017, www. healthline.com/health/breast-cancer/triple-negative-breast-cancer-treatment#treatment. Acce-ssed 1 June 2023.
21. Mayo Clinic. “Radiation Therapy for Breast Cancer - Mayo Clinic.” Mayoclinic.org, 2018, www.mayoclinic.org/tests-procedures/radiation-therapy-for-breast-cancer/about/pac-203849 40.
22. “Side Effects of Radiation for Breast Cancer: What to Know.” Www.medicalnewstoday.com, 5 Oct. 2018, www.medicalnewstoday.com/articles/323268#long-term-side-effects.
23. Clinic, Mayo. “Chemotherapy for Breast Cancer - Mayo Clinic.” Mayoclinic.org, 2018, www.mayoclinic.org/tests-procedures/chemotherapy-for-breast-cancer/about/pac-20384931.
24. Hosea, Ilyasha. “Stage III Triple-Negative Breast Cancer Survivor: How I Handled Treatment Side Effects.” MD Anderson Cancer Center, www.mdanderson.org/cancerwise/stage-iii-triple-negative-breast-cancer-survivor--how-i-handled-treatment-side-effects.h00-159300678.
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 3rd International Conference on Biological Engineering and Medical Science
- ISBN (Print)
- 978-1-83558-217-6
- ISBN (Online)
- 978-1-83558-218-3
- Published Date
- 20 December 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/22/20230958
- Copyright
- 20 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited